This is the first demonstration of donor microbes persisting in the recipient following fecal transplant, a finding made possible by a novel method to “fingerprint” individual strains of bacteria.
Investigators will have a state-of-the-art space to conduct safe and age-appropriate clinical research to advance the science and treatment of childhood diseases.
Priming the body to respond to immunotherapy with a new class of drugs: epigenetic modifiers.
UAB’s Community Health Innovation Awards honor job training programs, health and wellness, and mental health support.
The Clinical Trials Office and the UAB Center for Clinical and Translational Science will host its first Investigator Training Program on Saturday, Oct. 31 from 8 a.m. to 12:30 p.m. in the Wallace Tumor Institute.
A drug derived from female hormones that may help soldiers survive major blood loss on a battlefield will undergo first human testing at UAB.
UAB’s Community Engagement Institute brings academic researchers and community leaders together to brainstorm ways to improve Birmingham, the region and the world.
UAB’s Community Health Innovation Awards available to fund local projects aimed at community health issues.
The National Institutes of Health has awarded the University of Alabama at Birmingham Center for Clinical and Translational Science $33.59 million over four years to continue the center’s programs advancing translational research.
Donation from Dai-ichi Life Insurance Company and Protective Life Corporation will aid new disease-changing therapies in the ADDA pipeline.
Page 1 of 3